Medicare began covering certain GLP-1 weight loss drugs on July 1, 2026, giving millions of eligible beneficiaries access to ...

A new CMS proposed rule would reduce the burden of prior authorizations by further shortening payer decision timeframes and ...

The rollout of a pilot program testing the use of preapprovals in traditional Medicare and powered by artificial intelligence has not been smooth, physicians, patients and other clinicians say.

Ramya Ganti is the founder and CEO of Oprox, a VC-backed AI-native revenue intelligence platform for healthcare providers.

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

Humata Health, the leader in AI-powered medical review technology, today announced a new standalone prior authorization platform built for independent practices, regional health centers and specialty ...

By Samantha Liss and KFF Health News HealthDay ReportersTUESDAY, June 30, 2026 (HealthDay News) — Over four consecutive days ...

To improve transparency and accountability, the AMA urges CMS to strengthen how the rule is implemented and to expand the reporting framework. What’s the news: With the first reporting deadline come ...

After switching Medicare Advantage plans, a woman with a weakened immune system got tangled in the preapproval process, which ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

Pharmacy benefit managers sit at the center of a four-way transaction between patients, insurers, drug manufacturers, and ...